July 2025
1. MANARA P, Newsam AD, Venkatarame Gowda Saralamma V, Cunningham TA, et al
   Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy.
   Cancer Res. 2025 Jul 31. doi: 10.1158/0008-5472.CAN-24-3420.
   

   >> Share

   
   May 2024
2. ZHU J, Wang F, Wang L, Dai B, et al
   HDAC Inhibition Increases CXCL12 Secretion to Recruit Natural Killer Cells in Peripheral T Cell Lymphoma.
   Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-3250.
   

   >> Share

   
   April 2024
3. ITO Y, Marouf A, Kogure Y, Koya J, et al
   Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma.
   Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-24-0132.
   

   >> Share

   
   
4. XU X, Zhang Y, Lu Y, Zhang X, et al
   CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma.
   Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2874.
   

   >> Share

   
   January 2024
5. MARULLO R, Rutherford SC, Revuelta MV, Zamponi N, et al
   XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
   Cancer Res. 2024;84:101-117.
   

   >> Share

   
   October 2023
6. KNITTEL G, Reinhardt HC
   XPO1-mediated mRNA export of genome maintenance regulators drives chemotherapy resistance in aggressive lymphoma.
   Cancer Res. 2023 Oct 30. doi: 10.1158/0008-5472.CAN-23-2966.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share